article Open AccessTop 1% cited

The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer

BMC Cancer · 2019 · Vol. 19(1) · pp. 1091–1091

Ru Wang✉(Johns Hopkins University)Yayun Zhu(Johns Hopkins University)Xiaoxu Liu(First Affiliated Hospital of Xi'an Jiaotong University)Xiaoqin Liao(First Affiliated Hospital of Xi'an Jiaotong University)Jianjun He(First Affiliated Hospital of Xi'an Jiaotong University)Ligang Niu(First Affiliated Hospital of Xi'an Jiaotong University)

View via DOI Full-text PDF

Abstract

Stage IV breast cancer patients have different clinicopathological characteristics and survival outcomes according to different metastatic sites. Patients with bone metastasis have the best prognosis, and brain metastasis is the most aggressive subgroup.

Cancer Diagnosis and Treatment Breast Cancer Treatment Studies Metastasis and carcinoma case studiesMedicineBreast cancerOncologySurgical oncologyMetastasisInternal medicineBrain metastasisProportional hazards modelHazard ratioBone metastasis

MeSH terms

AdultAgedAged, 80 and overBreast NeoplasmsFemaleHumansMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisProportional Hazards ModelsSurvival AnalysisSEER ProgramKaplan-Meier EstimateYoung Adult